ahlam1399
08-07-2015, 03:12 AM
Allergan CEO says better to leave discoveries to others
Aug 6 (Reuters) - Allergan, which is selling its generics business to focus on branded ***** and aesthetics products, aims to acquire or license products that have already shown promise in studies,...http://feeds.feedburner.com/~ff/reuters/mergersNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/mergersNews?a=3Dmn5y3APLM:HHpeDVD7BPc:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=3Dmn5y3APLM:HHpeDVD7BPc:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/mergersNews?a=3Dmn5y3APLM:HHpeDVD7BPc:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=3Dmn5y3APLM:HHpeDVD7BPc:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/mergersNews?a=3Dmn5y3APLM:HHpeDVD7BPc:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/mergersNews/~4/3Dmn5y3APLM
Aug 6 (Reuters) - Allergan, which is selling its generics business to focus on branded ***** and aesthetics products, aims to acquire or license products that have already shown promise in studies,...http://feeds.feedburner.com/~ff/reuters/mergersNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/mergersNews?a=3Dmn5y3APLM:HHpeDVD7BPc:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=3Dmn5y3APLM:HHpeDVD7BPc:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/mergersNews?a=3Dmn5y3APLM:HHpeDVD7BPc:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=3Dmn5y3APLM:HHpeDVD7BPc:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/mergersNews?a=3Dmn5y3APLM:HHpeDVD7BPc:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/mergersNews/~4/3Dmn5y3APLM